CAMBRIDGE, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013 at 2:50 p.m. ET at the Boston Marriott Copley Place and at the Barclays Global Healthcare Conference on March 13, 2013 at 3:15 p.m. ET at the Loews Miami Hotel. The live and archived webcasts of the company presentations can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com . Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com .
CONTACT: Idenix Pharmaceuticals Contacts: Kelly Barry (617) 995-9033 (media) Teri Dahlman (617) 995-9807 (investors)